You are here

  • Home
  • Archive
  • Volume 73, Issue Suppl 2
  • OP0065 Initial Infliximab is not Cost-Effective in Otherwise Actively Treated Early Rheumatoid Arthritis. the 2-Year Follow-Up Results of the Randomized Clinical Neo-Raco Trial

Article metrics

Article menu
Download PDFPDF
EULAR 2014: Scientific Abstracts
Oral Presentations. Abstract session: What is new with anti-TNF's in RA
OP0065 Initial Infliximab is not Cost-Effective in Otherwise Actively Treated Early Rheumatoid Arthritis. the 2-Year Follow-Up Results of the Randomized Clinical Neo-Raco Trial

 

Online download statistics by month:

Online download statistics by month: June 2014 to March 2024

AbstractFullPdf
Jun 2014800
Jul 2014800
Aug 20141301
Sep 2014600
Oct 20141701
Nov 2014800
Dec 2014701
Jan 2015400
Feb 2015502
Mar 20152101
Apr 2015400
May 2015602
Jun 2015401
Jul 2015500
Aug 2015400
Sep 2015700
Oct 2015100
Nov 2015200
Dec 2015300
Jan 2016200
Feb 2016602
Mar 2016700
Apr 2016600
May 2016101
Jun 2016800
Jul 2016700
Aug 2016501
Sep 2016400
Oct 201612024
Nov 2016601
Dec 20162001
Jan 2017500
Feb 2017500
Mar 20171100
Apr 2017900
May 2017900
Jun 20171900
Jul 20171600
Aug 20173600
Sep 20172200
Oct 20171200
Nov 2017600
Dec 20172000
Jan 20181200
Feb 20182803
Mar 20182601
Apr 20185601
May 20182800
Jun 20181800
Jul 20182200
Aug 20181200
Sep 20181600
Oct 2018400
Nov 20181200
Jan 2019600
Feb 2019400
Apr 2019200
May 2019600
Jun 2019200
Jul 2019600
Aug 2019200
Oct 2019600
Feb 2020800
May 2020100
Jun 2020600
Jul 20201200
Aug 2020801
Sep 2020800
Oct 20201000
Nov 2020400
Feb 2021400
Mar 2021401
Apr 20211800
Oct 2021002
Nov 20211202
Dec 20211200
Jan 2022600
Feb 2022200
Mar 2022800
Apr 2022400
May 2022800
Jun 2022400
Jul 20221000
Aug 2022400
Sep 2022600
Oct 2022400
Nov 2022400
Dec 20221200
Jan 20231400
Feb 2023400
Mar 2023200
May 2023400
Jun 2023200
Jul 2023600
Aug 2023200
Sep 2023400
Nov 2023400
Dec 20231400
Jan 2024600
Mar 2024200
Total898050